Oruka Therapeutics, Inc.
General ticker "ORKA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $612.2M (TTM average)
Oruka Therapeutics, Inc. follows the US Stock Market performance with the rate: 53.8%.
Estimated limits based on current volatility of 2.9%: low 33.52$, high 35.50$
Factors to consider:
- Current price 58.1% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [11.49$, 27.48$]
- 2025-12-31 to 2026-12-31 estimated range: [8.82$, 21.65$]
Short-term ORKA quotes
Long-term ORKA plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $88.12MM |
| Operating Income | $-88.12MM |
| Non-Operating Income | $4.40MM |
| Interest Expense | $1.47MM |
| R&D Expense | $75.06MM |
| Income(Loss) | $-83.72MM |
| Profit(Loss)* | $-83.72MM |
| Stockholders Equity | $382.22MM |
| Assets | $396.02MM |
| Operating Cash Flow | $-57.84MM |
| Capital expenditure | $0.19MM |
| Investing Cash Flow | $-330.13MM |
| Financing Cash Flow | $449.54MM |
| Earnings Per Share** | $-4.99 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.